PADCEVTM (enfortumab vedotin) in Combination with pembrolizumab is Now Available for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer who are eligible for p
Published on: May 21, 2026, 3:43 p.m. | Source: Times of India
Health News: - First regimen to be approved in India to demonstrate superiority to platinum-containing chemotherapy, the current standard of care for adult pat.
